Endothelin-1 levels predict endothelial progenitor cell mobilization after acute myocardial infarction

Microvascular Research

Volumn 82, Issue 2, 2011, Pages 177-181

  Freixa, Xavier ^a   Masotti, Monica ^a   Palomo, Marta ^a   Diaz Ricart, Maribel ^a   Escolar, Ginés ^a   Guasch, Eduard ^a   Regueiro, Ander ^a   Jiménez, Marcelo ^a   Betriu, Amadeo ^a   Heras, Magda ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CELL COUNT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; STEM CELL MOBILIZATION;

ACUTE DISEASE; AGED; ANGIOGRAPHY; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960912636     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.06.008     Document Type: Article

References (31)

1. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N. Engl. J. Med. 1985, 312:932-936.
2. Bae J.H., Bassenge E., Kim M.H., et al. Impact of left ventricular ejection fraction on endothelial function in patients with coronary artery disease. Clin. Cardiol. 2004, 27:333-337.
3. Blann A.D., Woywodt A., Bertolini F., et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb. Haemost. 2005, 93:228-235.
4. Eitel I., Nowak M., Stehl C., et al. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging. Am. Heart J. 2010, 159:882-890.
5. Fadini G.P., Miorin M., Facco M., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. 2005, 45:1449-1457.
6. Fraccarollo D., Widder J.D., Galuppo P., et al. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction. Circulation 2008, 118:818-827.
7. Freixa X., Heras M., Ortiz J.T., et al. Usefulness of endothelin-1 assessment in acute myocardial infarction. Rev. Esp. Cardiol. 2011, 64:105-110.
8. Galiuto L., DeMaria A.N., del Balzo U., et al. Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography. Circulation 2000, 102:3111-3116.
9. Halcox J.P., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002, 106:653-658.
10. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593-600.
11. Iglarz M., Clozel M. Mechanisms of ET-1-induced endothelial dysfunction. J. Cardiovasc. Pharmacol. 2007, 50:621-628.
12. Khan S.Q., Dhillon O., Struck J., et al. C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Am. Heart J. 2007, 154:736-742.
13. Lee K.W., Lip G.Y., Tayebjee M., Foster W., Blann A.D. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005, 105:526-532.
14. Leone A.M., Rutella S., Giannico M.B., et al. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. Int. J. Cardiol. 2008, 130:457-462.
15. Li B., Sharpe E.E., Maupin A.B., et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 2006, 20:1495-1497.
16. Longmore D.B., Klipstein R.H., Underwood S.R., et al. Dimensional accuracy of magnetic resonance in studies of the heart. Lancet 1985, 1:1360-1362.
17. Matsuo S., Nakae I., Matsumoto T., Horie M. Impact of endothelial dysfunction on left ventricular remodeling after successful primary coronary angioplasty for acute myocardial infarction-analysis by quantitative ECG-gated SPECT. Ann. Nucl. Med. 2006, 20:57-62.
18. McClung J.A., Naseer N., Saleem M., et al. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia 2005, 48:345-350.
19. Mutin M., Canavy I., Blann A., Bory M., Sampol J., Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999, 93:2951-2958.
20. Niccoli G., Lanza G.A., Shaw S., et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. Eur. Heart J. 2006, 27:1793-1798.
21. Quilici J., Banzet N., Paule P., et al. Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes. Circulation 2004, 110:1586-1591.
22. Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001, 103:2776-2779.
23. Singh A.D., Amit S., Kumar O.S., Rajan M., Mukesh N. Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats. Basic Clin. Pharmacol. Toxicol. 2006, 98:604-610.
24. Sud N., Black S.M. Endothelin-1 impairs nitric oxide signaling in endothelial cells through a protein kinase Cdelta-dependent activation of STAT3 and decreased endothelial nitric oxide synthase expression. DNA Cell Biol. 2009, 28:543-553.
25. van 't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998, 97:2302-2306.
26. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001, 103:2885-2890.
27. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 2005, 353:999-1007.
28. Wojakowski W., Tendera M., Michalowska A., et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004, 110:3213-3220.
29. Wojakowski W., Tendera M., Zebzda A., et al. Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur. Heart J. 2006, 27:283-289.
30. Yip H.K., Wu C.J., Chang H.W., et al. Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty. Chest 2005, 127:1491-1497.
31. Zohlnhofer D., Dibra A., Koppara T., et al. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J. Am. Coll. Cardiol. 2008, 51:1429-1437.